leisure time -WSS

leisure time

author：comprehensive 2025-09-30 00:36:09 - browse：8335

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Microsoft's Peter Lee: Generative AI could help doctors be more human

focus

WSS

Why Talkspace is targeting Medicare, a tricky market

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

$1 billion proposal to grow Boston, Massachusetts biotech

Stem cell biologist probes earliest stages of human development

Study finds gene variants tied to breast cancer risk in Black women

Streamlined flu vaccines recommended by FDA advisory panel

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Stem cell biologist probes earliest stages of human development

What does generative AI mean for health care? We asked experts

First over

At least 13 dead in Texas as scorching temps continue

Longer MASH drug regimen improved liver, Akero study finds

Medical leaders decry Supreme Court decision on affirmative action

H5N1 virus can be tracked in retail milk, scientists say

How one medical school became remarkably diverse

Stem cell biologist probes earliest stages of human development

hotspot

Reports of telehealth's death have been greatly exaggerated

FDA poised to publish guidelines for clinical trial diversity

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Readout Newsletter: BridgeBio, Akero, and human embryo models

Why Talkspace is targeting Medicare, a tricky market

Addressing health care workers' trauma can help fight burnout

hotspot

focus

hotspot

knowledge